Wintrust Investments LLC Biogen Inc. Transaction History

Wintrust Investments LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $162,833 - $188,011	-615 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$258.66 - $342.55 $159,075 - $210,668	615 New	615 $165,000
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $87,583 - $121,019	-398 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$217.44 - $243.88 $86,541 - $97,064	398 New	398 $93,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Wintrust Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Wintrust Investments LLC with notifications on news.